| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8734672 | Revista Brasileira de Hematologia e Hemoterapia | 2017 | 6 Pages |
Abstract
Sickle cell anemia requires treatment and follow-up by a multiprofessional team. A current therapeutic option is hydroxyurea. This drug reduces complications and improves laboratorial parameters of patients. In this study, the use of the drug increased the hemoglobin and hematocrit levels of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Phelipe Gabriel dos Santos Sant'Ana, Ariane Moreira Araujo, Cynthia Teixeira Pimenta, Mário Lúcio Pacheco Ker Bezerra, SÃlvio Pereira Borges Junior, Viviana Martins Neto, Janaina Sousa Dias, Aline de Freitas Lopes, Danyelle Romana Alves Rios,